NEOM Investment Fund
NEOM Investment Fund is a seed to Series E stage investment firm. It has made 4 investments. 33% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $68.3M (across 5 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Aiman M. Al-Mudaifer
Member of the Board, Managing Director and CEO
Dr Manar Al Moneef
Chief Investment Officer
Denis Hickey
Chief Development Officer
Dr Paul Marshall
Head of Nature Region
Jassir Al-Jassir
Chief Governance, Risk and Compliance Officer
Rayan Fayez
Deputy CEO
Vishal Wanchoo
OXAGON CEO
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Liberation Labs | Bridge | $50.5M | Jan 2025 |
 Volocopter | Series E | $170M | Mar 2022 |
| LLiberation Bioindustries | Debt | $50.5M | — |
| LLiberation Bioindustries | Series A | — | — |
| LLiberation Bioindustries | Seed | $20M | — |
 Liberation Labs | Series A | $50.5M | — |
Top Co-Investors
Meach Cove Capital3 shared
New Agrarian3 shared
Siddhi Capital3 shared
Agronomics3 shared
Barclays1 shared
Honeywell Ventures1 shared
Intel Capital1 shared
NTT DOCOMO Ventures1 shared
Mercedes-Benz Group AG1 shared
GLy Capital Management1 shared
b2venture1 shared
Last updated: 20 October 2026